Table 3.

Kinetic parameters pertaining to inhibition of WT and Arg67His thrombin forms by AT and HCII in the absence and presence of GAGs*

AT inhibitionWTArg67His
 kon (M−1s−1kon (M−1s−1)  
No GAG 1.1 ± 0.2 × 104 1.0 ± 0.1 × 104 
With GAG 8.0 ± 0.1 × 107 5.2 ± 0.5 × 107 
HCII inhibition   
 kon(M−1 s−1kon(M−1 s−1)  
No GAG 1.0 ± 0.2 × 103 0.35 ± 0.05 × 103 
With GAG 5.1 ± 0.4 × 107 1.2 ± 0.2 × 105 
AT inhibitionWTArg67His
 kon (M−1s−1kon (M−1s−1)  
No GAG 1.1 ± 0.2 × 104 1.0 ± 0.1 × 104 
With GAG 8.0 ± 0.1 × 107 5.2 ± 0.5 × 107 
HCII inhibition   
 kon(M−1 s−1kon(M−1 s−1)  
No GAG 1.0 ± 0.2 × 103 0.35 ± 0.05 × 103 
With GAG 5.1 ± 0.4 × 107 1.2 ± 0.2 × 105 
F3-150

GAG is represented by high-molecular-weight heparin used at 70 nM in AT experiments, and by 25 μM dermatan sulphate in inhibition experiments with HCII.

or Create an Account

Close Modal
Close Modal